e-learning
resources
Glasgow 2004
Sunday 05.09.2004
Cellular and molecular strategies to repair the damaged lung
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Mesenchymal stem cells and their potential for clinical use
W. Noort (Amsterdam, The Netherlands)
Source:
Annual Congress 2004 - Cellular and molecular strategies to repair the damaged lung
Session:
Cellular and molecular strategies to repair the damaged lung
Session type:
Major Symposium
Number:
128
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
W. Noort (Amsterdam, The Netherlands). Mesenchymal stem cells and their potential for clinical use. Annual Congress 2004 - Cellular and molecular strategies to repair the damaged lung
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: Diagnostic tools for Obstructive Sleep Apnoea in adults and children
Expert interview: Physiological classification of lung function impairment
Occupational exposures to respiratory diseases: A case-based discussion
Related content which might interest you:
Mesenchymal stem cells in aging and IPF
Source: ERS Research Seminar 2017 – Integrating systems biology approach in idiopathic pulmonary fibrosis research
Year: 2016
Embryonic stem cells as source for endothelial cells for cell-based therapies
Source: Annual Congress 2010 - Pathobiology of pulmonary hypertension
Year: 2010
Oral presentation: Mesenchymal induction of lung endoderm progenitor cells from embryonic stem cells
Source: Lung Science Conference 2009 - Cell proliferation, Differentiation and Carcinogenesis
Year: 2009
Mesenchymal stromal cells in clinical trials: implications for emphysema
Source: International Congress 2017 – Repair of the emphysematous lung: mesenchymal stromal cell and matrix interactions
Year: 2017
Mesenchymal cells, immune cells and the lung stem cell niche
Source: Eur Respir Monogr 2021; 91: 134-143
Year: 2021
Mesenchymal stem cell therapy for severe emphysema
Source: Virtual Congress 2021 – Repair and regeneration in chronic lung disease and lung cancer
Year: 2021
Mesenchymal stem cell therapy for severe emphysema
Source: ERS Lung Science Conference 2021
Year: 2021
Mesenchymal stem cells and fibrotic lung diseases
Source: International Congress 2014 – Targeting lung fibrosis: from bench to bedside
Year: 2014
Induced pluripotent stem cell-derived alveolar epithelial cells: applications with lung-on-a-chip
Source: International Congress 2019 – Airway regenerative medicine: from bench to bedside
Year: 2019
Mesenchymal stem cells and recombinant erythropoietin treatment in an experimental sepsis model
Source: Annual Congress 2012 - The many roads to lung injury
Year: 2012
Mesenchymal stromal cells and macrophages in sepsis: new insights
Source: Eur Respir J, 51 (4) 1800510; 10.1183/13993003.00510-2018
Year: 2018
YI05 - Mesenchymal stromal cells identified in tissue from lung-transplanted patients
Source: Lung Science Conference 2012 - Rebuilding a diseased lung: Repair and regeneration
Year: 2012
Modelling human lung development and disease using pluripotent stem cells
Source: International Congress 2015 – Regenerative medicine of the lung: opportunities and threats
Year: 2015
Pulmonary transplantation of human induced pluripotent stem cell-derived macrophages
Source: International Congress 2019 – Airway regenerative medicine: from bench to bedside
Year: 2019
Induced pluripotent stem cells for generating lung airway stem cells and modelling respiratory disease
Source: Eur Respir Monogr 2021; 91: 190-204
Year: 2021
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept